A/APublished research associates this genotype (two copies of the reported risk allele) with a higher likelihood of Fasting plasma glucose compared to the general population.
A/GPublished research associates this genotype (one copy of the reported risk allele) with an intermediate association with Fasting plasma glucose.
G/GPublished research associates this genotype with typical/baseline likelihood of Fasting plasma glucose — no copies of the reported risk allele.
Genome medicine · 2017 · PMID 28270201 · open access
Questions about rs9873618
What is rs9873618?
rs9873618 is a single position in the genome, in or near the SLC2A2 gene. Published research associates it with fasting plasma glucose. A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.
Does rs9873618 affect how medicines work?
SLC2A2 carries pharmacogenomic findings for Metformin. That is educational information, not a prescription or a dosing guide. Any decision to start, stop or change a medicine belongs with the clinician or pharmacist managing your treatment.
Does having rs9873618 mean I will get this?
No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.
Where does the information about rs9873618 come from?
GWAS Catalog, Genome Med 2017, PMID:28270201. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.